NKA Bio is developing therapeutic antibodies
to buy more time for life-saving care
About NKA Bio
Who:
NKA Bio is developing new medicines to improve critical care. Our lead product is NKA01, a temperature-stable antibody for trauma patients.
Problem:
When you are severely injured, it is a race against time to get to surgery. The average person dies 8 minutes before lifesaving treatment can be delivered.
Solution:
But in the future, when minutes count, our antibody will buy hours. At NKA Bio, our treatment presses pause on death. With an injection of NKA01 by EMS, our drug could buy more time for transport and lifesaving surgery.
The Problem
When you are severely injured, it is a race against time to get to surgery, because the average person dies 8 minutes before lifesaving treatment can be delivered.
In Addition to the 90,000 trauma patients who don't live long enough to get to a hospital... Every year:
Our Solution
Introducing NKA01
When minutes count, our antibody buys hours. NKA01 presses pause on death with a low-volume injection at the point of injury to buy more time for transport and lifesaving surgery.
Product:
Prefilled Syringe with our Anti-Shock Toxin Antibody for Injection by EMS during their standard treatment protocols to prepare the patient for transport.
Key Features:
Temperature stable and low volume for field use by EMS to immediately stabilize trauma patients and press pause on death to buy more time for transport to a trauma center for care.
Progress to Date:
Proof of Concept In Vivo with a Prototype. Lead Candidate Selected.
Pipeline
Critical Care Focused
World Health Organization
Team
Shock Pioneer Behind Discovery
(1932 - 2020)
Dr. Gann was a pioneer and leader in trauma care and biomedical engineering, serving as the first Director of Emergency Medicine at Johns Hopkins and the first Chair of Biomedical Engineering at Case Western Reserve. A polymath with a background in physics, philosophy, and medicine, Dr. Gann's research was continuously funded by the NIH to study the body's response to hemorrhage.
Donald S. Gann, MD
SUPPORT
Advisors